The reference architecture connects enterprise and public scientific data to accelerate target identification and compound ...

As healthcare organizations look to leverage agentic artificial intelligence technologies, Wolters Kluwer Health is developing the foundational capabilities to support AI agents for medication ...

In the ultracompetitive world of drug development, getting a new medication on the market as fast as possible can have major ...

Edison is the commercial spinout of FutureHouse, an AI scientist non-profit backed by former Google CEO Eric Schmidt and co-founded by Sam Rodriques, PhD, former group leader at the Francis Crick ...

Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on drug discovery and research available to the broader healthcare industry, ...

Scalable, parallel drug design: one researcher can run multiple campaigns simultaneously across targets and modalities * From research goal to lab ...

Matthew Gallagher launched Medvi, a GLP-1 telehealth company, from his Los Angeles home in September 2024. Fourteen months ...

The state of Utah has embarked on the first test of artificial intelligence as an autonomous clinical decision-maker under a regulatory suspension paradigm with AI company Doctronic. Rather than wait ...

A Google DeepMind paper maps six attack categories against autonomous AI agents—from invisible HTML commands to multi-agent ...

AI agents are starting to work in teams, but without careful organization, groups of bots can easily fall into chaos.